Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.

@article{Grebely2017EliminationOH,
  title={Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.},
  author={Jason Grebely and Julie Bruneau and Philip Bruggmann and Magdalena Harris and Matthew Hickman and Tim Rhodes and Carla Treloar},
  journal={The International journal on drug policy},
  year={2017},
  volume={47},
  pages={
          26-33
        }
}
Grebely, J; Bruneau, J; Bruggmann, P; Harris, M; Hickman, M; Rhodes, T; Treloar, C; International Network on Hepatitis in Substance Users; International Network on Hepatitis in Substance Users; (2017) Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy. The International journal on drug policy, 47. pp. 26-33. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.08.001 Downloaded from: http://researchonline.lshtm.ac.uk/4363442… CONTINUE READING
6
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Hepatitis C virus infection in Irish drug users and prisoners – a scoping review

  • BMC Infectious Diseases
  • 2019
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 94 REFERENCES

Global Hepatitis Report 2017

WHO.
  • . In W. H. Organization (Ed.). Geneva: World Health Organization.
  • 2017
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Efficacy and safety

J. Grebely, O. Dalgard, +27 authors G. J. Dore
  • 2017

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2017

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

European Union, H.C.V.C.
  • Lancet Gastroenterol Hepatol, 2, 325-336.
  • 2017